ES2051013T3 - Procedimiento de preparacion de compuesto ligando-receptor. - Google Patents

Procedimiento de preparacion de compuesto ligando-receptor.

Info

Publication number
ES2051013T3
ES2051013T3 ES90904856T ES90904856T ES2051013T3 ES 2051013 T3 ES2051013 T3 ES 2051013T3 ES 90904856 T ES90904856 T ES 90904856T ES 90904856 T ES90904856 T ES 90904856T ES 2051013 T3 ES2051013 T3 ES 2051013T3
Authority
ES
Spain
Prior art keywords
alpha
ligando
preparation procedure
composite preparation
galactose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90904856T
Other languages
English (en)
Inventor
Alain Denis
Claudine Kieda
Michel Monsigny
Pierre Perrier
Gerard Redziniak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parfums Christian Dior SA
Original Assignee
Parfums Christian Dior SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parfums Christian Dior SA filed Critical Parfums Christian Dior SA
Application granted granted Critical
Publication of ES2051013T3 publication Critical patent/ES2051013T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/42—Colour properties
    • A61K2800/43—Pigments; Dyes
    • A61K2800/434—Luminescent, Fluorescent; Optical brighteners; Photosensitizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/61—Surface treated
    • A61K2800/612—By organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/65—Characterized by the composition of the particulate/core
    • A61K2800/654—The particulate/core comprising macromolecular material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Nanotechnology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION SE REFIERE A PRODUCTOS DESTINADOS A FIJARSE ESPECIFICAMENTE SOBRE LA MEMBRANA DE UN QUERATINOCITO MEDIANTE UN ENLACE LIGANDO-RECEPTOR. ESTOS PRODUCTOS SON PORTADORES DE AL MENOS UN LIGANDO CONSTITUIDO POR UN RESIDUO OSIDICO ELEGIDO ENTRE LA ALFA-L-RAMOSA, LA ALFA-D-GALACTOSA Y EL ALFA-D-GALACTOSA-6-FOSFATO. GRACIAS A ESTA ESPECIFICIDAD, ES POSIBLE PREPARAR COMPOSICIONES COSMETICAS O FARMACEUTICAS QUE PRESENTA EN PARTICULAR UNA EFICACIA MEJORADA, POR EJEMPLO PARA REGENERAR LA EPIDERMIS, PARA TRATAR LA SORIASIS, PARA EL CRECIMIENTO DEL CABELLO.
ES90904856T 1989-03-20 1990-03-16 Procedimiento de preparacion de compuesto ligando-receptor. Expired - Lifetime ES2051013T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8903628A FR2645741B1 (fr) 1989-03-20 1989-03-20 Procede pour fixer un produit sur la membrane d'un keratinocyte au moyen d'une liaison ligand-recepteur, procede de preparation d'un tel produit, produit obtenu, composition cosmetique ou pharmaceutique le contenant et son procede de preparation

Publications (1)

Publication Number Publication Date
ES2051013T3 true ES2051013T3 (es) 1994-06-01

Family

ID=9379873

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90904856T Expired - Lifetime ES2051013T3 (es) 1989-03-20 1990-03-16 Procedimiento de preparacion de compuesto ligando-receptor.

Country Status (8)

Country Link
US (1) US5286629A (es)
EP (1) EP0464077B1 (es)
JP (1) JP2856547B2 (es)
CA (1) CA2056357C (es)
DE (1) DE69006496T2 (es)
ES (1) ES2051013T3 (es)
FR (1) FR2645741B1 (es)
WO (1) WO1990011069A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5603872A (en) * 1991-02-14 1997-02-18 Baxter International Inc. Method of binding recognizing substances to liposomes
JP3407072B2 (ja) * 1991-02-14 2003-05-19 バクスター、インターナショナル、インコーポレイテッド リポソームへの認識物質の結合
CA2078388A1 (en) * 1991-10-02 1993-04-03 Mridula Nair Biocompatible emulsion particles
US5466675A (en) * 1992-02-04 1995-11-14 Piljac; Goran Immunological activity of rhamnolipids
BE1005704A4 (nl) * 1992-02-04 1993-12-21 Piljac Goran & Piljac Visnja Farmaceutisch preparaat op basis van rhamnolipide.
US5455232A (en) * 1992-02-04 1995-10-03 Piljac; Goran Pharmaceutical preparation based on rhamnolipid
GB9208339D0 (en) * 1992-04-15 1992-06-03 Unilever Plc Treatment composition
FR2730409B1 (fr) * 1995-02-15 1997-05-09 Dior Christian Parfums Utilisation des galactolipides, en particulier galactosylglycerides, et des extraits d'origine naturelle contenant ces produits, dans les domaines cosmetiques, pharmaceutique et notamment dermatologique
FR2757391B1 (fr) * 1996-12-20 1999-03-12 Dior Christian Parfums Utilisation d'un extrait de la plante terminalia, dans les domaines cosmetique et pharmaceutique, notamment dermatologique
DE19755966B4 (de) * 1997-12-16 2004-08-05 Urs J. Dr. Hänggi Verwendung von Formulierungen von wasserfesten, biologisch abbaubaren Polymeren aus nachwachsenden Rohstoffen mit erhöhter Bindungsaffinität zur Herstellung von Trägern für Analysensysteme und Testsysteme aus diesen Formulierungen
US6958148B1 (en) * 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
EP1043016B1 (en) * 1999-03-30 2014-08-20 Sodic Sa A plant extract based on glycerides,phospholipids and phytosphingolipids, a method for the preparation of this extract and a cosmetic composition containing the same
US6821509B2 (en) * 2000-04-14 2004-11-23 Cosmetica, Inc. Nanoscopic hair care products
CN1436068A (zh) * 2000-04-14 2003-08-13 考斯迈提科公司 纳米级的头发护理产品
FR2819721B1 (fr) † 2001-01-19 2005-02-04 L M D Traitement des escarres avec sucre non metabolisable et un absorbant polymerique
US20040126900A1 (en) * 2001-04-13 2004-07-01 Barry Stephen E High affinity peptide- containing nanoparticles
DE10121092A1 (de) * 2001-04-26 2002-10-31 Beiersdorf Ag Kosmetische oder dermatologische Formulierungen mit einem Gehalt an Sericosid und/oder Pflanzenextrakten, dasselbe enthaltend
US20030031689A1 (en) * 2001-08-09 2003-02-13 Thomas Mammone Method of skin exfoliation
KR100492913B1 (ko) * 2002-08-23 2005-06-03 주식회사 태평양 피부 감작 및 자극을 완화하는 피부 외용제 조성물
CN1228042C (zh) * 2003-01-30 2005-11-23 上海家化联合股份有限公司 积雪草甙脂质体及其用途
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
JP2009504661A (ja) * 2005-08-09 2009-02-05 ソーン・ラブズ・エルエルシー ヘアホールド配合物
US9445975B2 (en) * 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
CN114469920B (zh) * 2022-03-31 2023-09-15 中国医学科学院整形外科医院 维甲酸和/或鼠李糖在制备药物和/或器械中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969540A (en) * 1975-09-11 1976-07-13 Albion Laboratories, Inc. Enzymatically prepared metal proteinates
US4310505A (en) * 1979-11-08 1982-01-12 California Institute Of Technology Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances
US4508693A (en) * 1983-11-29 1985-04-02 Shell Oil Co. Solution removal of HCN from gaseous streams, with pH adjustment of reacted solution and hydrolysis of thiocyanate formed
SE8501613D0 (sv) * 1985-04-01 1985-04-01 Bio Carb Ab Foreningar for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling
ES2033667T3 (es) * 1985-10-23 1993-04-01 Dr. Kurt Mulli Nachf. Gmbh & Co. Kg Composicion farmaceutica que contiene fracciones de extractos de timo.
GB8604983D0 (en) * 1986-02-28 1986-04-09 Biocompatibles Ltd Protein preservation
PH26549A (en) * 1987-04-03 1992-08-19 Meito Sangyo Kk Mannobiose derivatives
FR2609397B1 (fr) * 1988-02-23 1991-12-13 Serobiologiques Lab Sa Utilisation d'une substance ou composition de nature glucidique comme principe actif d'une composition dermatologique et/ou cosmetologique et/ou pharmaceutique et/ou stimulante cellulaire, et composition contenant une telle substance ou composition de nature glucidique

Also Published As

Publication number Publication date
EP0464077B1 (fr) 1994-02-02
EP0464077A1 (fr) 1992-01-08
CA2056357C (en) 2002-01-08
JP2856547B2 (ja) 1999-02-10
DE69006496T2 (de) 1994-08-18
US5286629A (en) 1994-02-15
FR2645741B1 (fr) 1995-06-23
WO1990011069A1 (fr) 1990-10-04
CA2056357A1 (en) 1990-09-21
DE69006496D1 (de) 1994-03-17
FR2645741A1 (fr) 1990-10-19
JPH04504120A (ja) 1992-07-23

Similar Documents

Publication Publication Date Title
ES2051013T3 (es) Procedimiento de preparacion de compuesto ligando-receptor.
ES2188147T3 (es) Anti-irritantes en composiciones cosmeticas.
ES2120274T3 (es) Utilizacion de un extracto de una bacteria filamentosa no fotosintetica y composicion.
ES2049695T1 (es) Procedimiento para la obtencion de cera de manzana, cera de manzana asi obtenida y productos cosmeticos que contienen cera de manzana.
ES2145836T3 (es) Copolimeros elastomericos termoplasticos injertados de silicona, y composiciones que los contienen para el cuidado del pelo y la piel.
ES2145143T3 (es) Copolimeros elastomericos termoplasticos y composiciones que los contienen para el cuidado del cabello y de la piel.
ES2177636T3 (es) Utilizacion del agua empobrecida en deuterio en la preparacion de cosmeticos.
ES2227527T3 (es) Un factor de crecimiento de queratinocitos (kgf) truncado que tiene actividad biologica aumentada.
ES2171746T3 (es) Empleo de epinastina para el tratamiento de dolores.
AR005940A1 (es) Composicion cosmetica de fijacion y brillo en aerosol, y procedimiento
AR016751A1 (es) Metodo para inhibir la liberacion del peptido beta-amiloide en una celula, composicion farmaceutica y compuestos utiles en dicho metodo
ES2167717T3 (es) Nuevos aminoacidos ciclicos sustituidos como agentes farmaceuticos.
ES2106701T3 (es) Producto para la decoloracion del cabello.
ES2183157T3 (es) Composiciones para el cuidado del cabello.
ES2130868T3 (es) Utilizacion de un extracto de al menos una iridacea en el tratamiento de las arrugas.
ES2174248T3 (es) Composiciones para la eliminacion de una placa dental.
AR022333A1 (es) Regenerador de tejido oseo
ES2111412T3 (es) Aplicador de espuma para el cuidado y el tratamiento topico de la piel.
ES2127490T3 (es) Utilizacion de un aceite rico en acido petroselenico como agente hidratante.
ES2124638T3 (es) Composicion cosmetica que comprende un polimero fijante y un almidon anfotero.
ES2192680T3 (es) Nuevos derivados de vitamina d con sustituyentes carbo- o heterociclicos en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos.
AR000709A1 (es) Una composicion para la tintura de oxidacion de las fibras queratinicas, procedimiento de tintura que emplea esta composicion y dispositivo de varios compartimientos que comprende dicha composicion.
ES2163896T3 (es) Composiciones para aumentar la concentracion y/o motilidad de los espermatozoos en humanos.
HUP9900511A2 (hu) Legalább egy béta-adrenergiás agonista alkalmazása P anyag antagonistaként és kozmetikai kezelési eljárás
ES2530510T3 (es) Constructos peptídicos sintéticos para el diagnóstico y tratamiento de periodontitis asociada con Porphyromonas gingivalis

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 464077

Country of ref document: ES